Ginkgo Bioworks Holdings Inc Class (DNA)
Operating Cash Flow (Statement)
-$170.24M
TTM · Period ending: · USD
DNA Operating Cash Flow (Statement)
Latest reported-$170.24Mperiod ending
Latest reported-$170.24Mperiod ending
DNA TTM Cash from Operations (-$135.83M → -$170.24M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DNA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -170,243,000 | |
| -166,224,000 | |
| -171,059,000 | |
| -165,816,000 | |
| -237,711,000 | |
| -281,847,000 | |
| -319,585,000 | |
| -334,981,000 | |
| -305,031,000 | |
| -294,174,000 | |
| -295,500,000 | |
| -342,200,000 | |
| -297,121,000 | |
| -322,885,000 | |
| -252,198,000 | |
| -313,208,000 | |
| -289,971,000 | |
| -225,585,000 | |
| -253,818,000 | |
| -147,616,000 | |
| -167,651,000 | |
| -159,949,000 | |
| -135,830,000 |